Daniel P Flaherty Selected Research

Daniel P Flaherty Research Topics

6	Neoplasms (Cancer) 03/2024 - 12/2016
3	Neurodegenerative Diseases (Neurodegenerative Disease) 03/2024 - 01/2020
3	Infections 01/2023 - 01/2021
3	Pain (Aches) 01/2022 - 01/2019
2	Chronic Pain 01/2022 - 01/2019
1	Pulmonary Hypertension 05/2024
1	Pulmonary Arterial Hypertension 05/2024
1	Lymphoma (Lymphomas) 03/2024
1	Melanoma (Melanoma, Malignant) 03/2024
1	Chronic Renal Insufficiency 11/2023
1	Malaria 10/2023
1	Epilepsy (Aura) 01/2023
1	Endocarditis 01/2023
1	Glaucoma 01/2023
1	Hypertension (High Blood Pressure) 01/2023
1	Sepsis (Septicemia) 01/2021
1	Genomic Instability 01/2019
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2016

3	Deubiquitinating EnzymesIBA 05/2024 - 02/2021
3	Adenylyl Cyclases (Adenylyl Cyclase)IBA 03/2024 - 01/2019
3	Ubiquitin Thiolesterase (Ubiquitin Carboxy-Terminal Hydrolase)IBA 03/2024 - 01/2020
2	UbiquitinIBA 05/2024 - 03/2024
2	Proteasome Endopeptidase Complex (Proteasome)IBA 05/2024 - 03/2024
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2023 - 01/2021
2	adenylyl cyclase 1IBA 01/2022 - 01/2022
2	Calmodulin (Calcium-Dependent Activator Protein)IBA 01/2022 - 01/2019
1	Proteins (Proteins, Gene)FDA Link 05/2024
1	Protein Isoforms (Isoforms)IBA 03/2024
1	IndicanIBA 11/2023
1	artemisinin (artemisinine)IBA 10/2023
1	Carbonic Anhydrases (Carbonic Anhydrase)IBA 01/2023
1	PyrimidinonesIBA 01/2022
1	Linezolid (Zyvox)FDA Link 01/2021
1	dorzolamide (Trusopt)FDA LinkGeneric 01/2021
1	1,3,4-oxadiazoleIBA 01/2019
1	Analgesics (Analgesic Drugs)IBA 01/2019
1	Nucleic AcidsIBA 01/2019
1	5' Untranslated Regions (5' UTR)IBA 01/2019
1	ErbB Receptors (EGF Receptor)IBA 12/2016
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 12/2016
1	dolichyl-diphosphooligosaccharide - protein glycotransferase (oligosaccharyltransferase)IBA 12/2016
1	Glycoproteins (Glycoprotein)IBA 12/2016
1	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 12/2016

4	Therapeutics 03/2024 - 01/2021